Japan Digital Genome Market Insight
Published: 04 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
Japan Digital Genome Market will grow at a rate of 10.48% due to rising demand for accurate sequencing devices, genomic data management and laboratory automation, the precision medicine sector.
Japan Digital Genome Market Insights Forecasts to 2035
- The Japan Digital Genome Market Size Was Estimated USD 1,450.0 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 10.48% from 2025 to 2035
- The Japan Digital Genome Market Size is Expected to rise around USD 3,928.5 Million by 2035
Notable Insights for the Japan Digital Genome Market
- Segmentation on the basis of Product Type indicates that Next-Generation Sequencing (NGS) Platforms and precision software systems dominate Japan market in 2025 with 48% share across biotech and clinical laboratories industries.
- Segmentation on the basis of Application indicates that Personalized Medicine, Drug Discovery and Clinical Diagnostics segment dominates Japan Digital Genome Market 2025 with 53% share, driven by biomarker discovery and genomic interpretation demand.
- World-wide projected revenue of Illumina, Inc. in fiscal year 2025 would be around $4.6 billion, owing to high demand for advanced sequencing systems, consumable reagent kits, and digital genomic analytics workflows.
- It is expected that increasing modernization in genomic repositories, quality control needs in bio-manufacturing, and adoption of digital sequencing data systems would contribute in driving the growth of the market, where digital genome workflows offer precise diagnostic accuracy up to 42%, and minimize interpretation pipeline processing errors up to 31%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in precision molecular analysis, modernization in sequencing instruments, and development in bioinformatics data platforms on the Japan Digital Genome Market growth.
- Provides strategic insights regarding technology innovation such as cloud-based sequencing technology, artificial intelligence-based variant calling technology, smart laboratory analytical models, and real-time genomic sequence tracking systems.
- Assists players to analyze competitive benchmarking, investment in high-throughput sequencing technology, automation in bio-pharmaceutical processes, and expansion in genetic test centers by major diagnostics platform suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Digital Genome Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Digital Genome Market
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen N.V.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Takara Bio Inc.
- Sysmex Corporation
- BGI Group
- Eurofins Genomics K.K.
- Macrogen Japan Corp.
Recent Developments:
- In March 2026, Takara Bio Inc. introduced smart alignment-enabled genomic analysis platforms integrated with cloud-based laboratory monitoring technologies for high-throughput precision medicine testing architectures.
- In September 2025, Sysmex Corporation launched next-generation sequencing automation software systems optimized for clinical oncology profiling, liquid biopsy screening, and academic research architectures requiring high-precision molecular classification.
Market Segmentation:
Japan Digital Genome Market, By Product Type
- Next-Generation Sequencing Platforms
- Sanger Sequencing Hardware
- Bioinformatics Analysis Software
- Genomic Sample Preparation Kits
- Cloud Data Management Tools
Japan Digital Genome Market, By Technology
- AI-Based Variant Calling Systems
- IoT-Enabled Bio-Repository Units
- Digital Molecular Diagnostic Processing
- Cloud-Based Sequencing Pipeline Tools
- Automated DNA Extraction Solutions
Japan Digital Genome Market, By Application
- Personalized Healthcare
- Biomedical & Academic Research Institutes
- Clinical Diagnostics and Oncology
- Agricultural & Livestock Bio-Tech
- Pharmaceutical & Drug Development Processes
Expert Views:
Japan's Digital Genome Market is positioned for sustained expansion, driven by accelerating adoption of precision medicine, advanced sequencing technologies, and AI-powered genomic analytics. Growing investments in laboratory automation, cloud-based bioinformatics, and personalized healthcare will strengthen diagnostic accuracy and research efficiency. Continuous innovation by global and domestic industry leaders is expected to enhance competitiveness, supporting long-term market growth through 2035.
Author: Sanket and Pranali By Decisions Advisors and Consulting